Story perspectives

Connecticut AG Leads Push to Ease Mifepristone Restrictions

8/22/2025

50 6

Summary

Story summary

Connecticut Attorney General William Tong and 16 others petitioned the FDA to remove restrictions on mifepristone, used in medication abortions.
They assert that current FDA requirements limit patient access and are politically driven rather than safety-based.
Mifepristone has been FDA-approved since 2000, with over 7.5 million safe uses documented.
The petition responds to a disputed report alleging increased adverse events, criticized for lacking peer review.
Tong highlights the importance of patient rights and access to safe abortion options.

1 of 1

Story summary

Connecticut Attorney General William Tong and 16 others petitioned the FDA to remove restrictions on mifepristone, used in medication abortions.
They assert that current FDA requirements limit patient access and are politically driven rather than safety-based.
Mifepristone has been FDA-approved since 2000, with over 7.5 million safe uses documented.
The petition responds to a disputed report alleging increased adverse events, criticized for lacking peer review.
Tong highlights the importance of patient rights and access to safe abortion options.